Su-Xia Lin
Impact in
-
- Glioma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
Papers in
- Oncology 6
- Viral-associated cancers and disorders 3
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 1
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Hong-Yun Zhao (2 shared papers)Yan Gao (3 shared papers)Qiu-Liang Wu (1 shared paper)Mian Xie (1 shared paper)Jing Zeng (1 shared paper)Hui-Qiang Huang (3 shared papers)Fei Xu (1 shared paper)Li Zhang (1 shared paper)
In The Last Decade
Su-Xia Lin
9 papers receiving 280 citations
Peers
Comparison fields: 5 of 39
- Genetics 56
- Oncology 140
- Cell Biology 75
- Pathology and Forensic Medicine 82
- Immunology 93
Countries citing papers authored by Su-Xia Lin
This map shows the geographic impact of Su-Xia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su-Xia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su-Xia Lin more than expected).
Fields of papers citing papers by Su-Xia Lin
This network shows the impact of papers produced by Su-Xia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su-Xia Lin. The network helps show where Su-Xia Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Su-Xia Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 77 | |
| 2 | 2011 | 71 | |
| 3 | 2016 | 59 | |
| 4 | 2015 | 17 | |
| 5 | 2018 | 17 | |
| 6 | 2012 | 16 | |
| 7 | 2019 | 13 | |
| 8 | 2014 | 11 | |
| 9 | 2013 | 3 |
About Su-Xia Lin
Su-Xia Lin is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Molecular Biology and Genetics, having authored 9 papers that have together received 284 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Immune cells in cancer (2 papers), Immune Cell Function and Interaction (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Treatment and Pharmacology (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Genetics (56 citations), Oncology (140 citations), Cell Biology (75 citations), Pathology and Forensic Medicine (82 citations) and Immunology (93 citations). Su-Xia Lin has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Hong-Yun Zhao, Yan Gao, Qiu-Liang Wu, Mian Xie, Jing Zeng, Hui-Qiang Huang, Fei Xu, Li Zhang, Xin-Ke Zhang and Jia-Bin Lu. Their work appears in journals such as Cell Death Discovery, Journal of Thoracic Oncology, Oncotarget, Diagnostic Pathology and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.